Bajaj Healthcare gets CDSCO nod for phase III trials of suvorexant tablets for insomnia

Suvorexant is a prescription drug used for treating insomnia in adults. It acts on the central nervous system to regulate the sleep-wake cycle, helping patients achieve better sleep onset and maintenance. Shares of Bajaj Healthcare Ltd ended at ₹482.60, up by ₹2.95, or 0.62%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *